Related references
Note: Only part of the references are listed.Enterotypes of the human gut microbiome
Manimozhiyan Arumugam et al.
NATURE (2011)
Postprandial Changes in Small Bowel Water Content in Healthy Subjects and Patients With Irritable Bowel Syndrome
Luca Marciani et al.
GASTROENTEROLOGY (2010)
The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome
Tamira K. Klooker et al.
GUT (2010)
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study
R. Corinaldesi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Postinfectious Irritable Bowel Syndrome
Robin Spiller et al.
GASTROENTEROLOGY (2009)
Non-invasive quantification of small bowel water content by MRI: a validation study
C. L. Hoad et al.
PHYSICS IN MEDICINE AND BIOLOGY (2007)
Economic evaluation of tegaserod vs. placebo in the treatment of patients with irritable bowel syndrome:: An analysis of the TENOR study
Andrea Bracco et al.
VALUE IN HEALTH (2007)
Immune activation in patients with irritable bowel syndrome
Tobias Liebregts et al.
GASTROENTEROLOGY (2007)
Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum
Mar Guilarte et al.
GUT (2007)
Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes
Simon P. Dunlop et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Functional bowel disorders
George F. Longstreth et al.
GASTROENTEROLOGY (2006)
Physical symptom disorder: A simpler diagnostic category for somatization-spectrum conditions
K Kroenke
JOURNAL OF PSYCHOSOMATIC RESEARCH (2006)
Measuring health-related quality of life in patients with irritable bowel syndrome: Can less be more?
JM Lackner et al.
PSYCHOSOMATIC MEDICINE (2006)
Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome
JH Park et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS
SP Dunlop et al.
GASTROENTEROLOGY (2003)
Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome
SP Dunlop et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Prognosis in post-infective irritable bowel syndrome: a six year follow up study
KR Neal et al.
GUT (2002)
Activation of the mucosal immune system in irritable bowel syndrome
VS Chadwick et al.
GASTROENTEROLOGY (2002)
Share Paper
